Meridian Bioscience Reports First Quarter 2014 Operating Results, Declares Increased Regular Cash Dividend, and Reaffirms Fiscal 2014 Guidance

CINCINNATI---- Meridian Bioscience, Inc.today:reported first quarter net sales of $44.8 million, a decrease of 1% from the same period of the prior fiscal year; reported first quarter operating income of $11.6 million, a decrease of 11% from the same period of the prior fiscal year; reported first quarter net earnings of $7.4 million, or $0.18 [...]

Hamilton Robotics Partners with Coastal Genomics to Introduce Innovative Technologies to Automate Agarose Gel DNA Fragment Selection

SAN DIEGO, Calif. -– At the annual Society for Laboratory Automation and Screening (SLAS) meeting Hamilton Robotics has announced a partnership with Coastal Genomics to launch the new Microlab® NIMBUS® Select workstation with Ranger Technology. The new automated workstation provides a faster and more economical automated solution to agarose gel selection of DNA fragments, generating [...]

NIH and Appistry Partner to Implement Genetic Analysis Pipeline for Undiagnosed Diseases Program

ST. LOUIS, MO – Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, is partnering with the Undiagnosed Diseases Program (UDP) at the National Institutes of Health (NIH) to implement a unique genetic-analysis pipeline for patient diagnosis. Assembled by the NIH and brought into production by Appistry, the pipeline considers [...]

Markes International shapes the future of GC–MS by launching a new variable-energy electron ionisation technology

Markes International (Llantrisant, UK), a world leader in instrumentation for trace organic analysis, has announced the launch of a variable-energy electron ionisation source technology for GC–MS, Select-eV®. By enabling the energy of ionising electrons to be changed, Select-eV breaks new ground in the field of GC–MS. It allows the production of reference-quality electron ionisation mass [...]

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Chooses Genedata Expressionist for Oncology Research

Basel, Switzerland -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (IKP) has selected Genedata Expressionist® as the bioinformatics platform for pharmacogenomics- and oncology-related translational research. IKP, one of the premier clinical research facilities in Germany, focuses on [...]

Spectro Inc. to Develop and Enhance Its Fluid Analysis Products with LaserNet Fines® Technology Licensing Agreement

(CHELMSFORD, MA). Spectro Inc. and Lockheed Martin Corporation have signed an exclusive licensing agreement for Lockheed Martin’s LaserNet Fines® (LNF) fluid imaging and classification technology. The agreement will enable Spectro, a leading developer and manufacturer of analytical tools and software for fluid and machine condition monitoring, to enhance its present products and develop and manufacture [...]

Artel Acquires Software to Expand Its Liquid Handler Performance Verification Capabilities

Westbrook, Maine – Artel, the leader in liquid handling quality assurance, announced today that it has acquired exclusive rights to the LabGauge product line from Louisville, Kentucky-based StackWave. The software will be used with Artel’s MVS® Multichannel Verification System to deliver increased information availability and management. The prototype technology was described in an article, “High-Throughput [...]

The New York Genome Center Purchases Illumina HiSeq X Ten Sequencing System

New York, NY. The New York Genome Center (NYGC) announced the acquisition from Illumina of a HiSeq X Ten system, which is expected to enable ultra-high throughput sequencing of whole human genomes. This advanced technology is designed to provide a prompt readout of the entire genome, dramatically enhancing the turnaround for valuable genomic information. With [...]

Microbix Finances Development of LumiSort® Prototype Instrument

TORONTO — Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, announced today it has signed a letter of intent to finance the development of the LumiSort® prototype instrument for its semen sexing technology. LumiSort® is a completely new instrument-based livestock sex selection technology that will significantly improve the yield and quality [...]

Sigma-Aldrich® Named to “Global 100 Most Sustainable Corporations in the World” List

ST. LOUIS, Sigma-Aldrich Corporation (Nasdaq: SIAL) was named today for the first time to the "Global 100 Most Sustainable Corporations in the World" list in an announcement made earlier at the World Economic Forum in Davos, Switzerland. The St. Louis-based Company was ranked 20th, one of the highest rankings among its peers. "We are excited [...]

Access IBO on Knowledge Center